Skip to content
RegenCompliance
All articles
Specialty playbook

Midwifery and Doula Services Marketing Compliance: State Licensure Variation, Scope of Practice, and Birth-Outcome Claims

Midwifery licensing varies enormously by state. Doulas aren't licensed but still face FTC rules on claims. Here's the compliance framework for pregnancy-adjacent services.

7 min readBy RegenCompliance Editorial, FDA/FTC compliance desk

Midwifery and doula services operate under some of the most variable licensing rules in healthcare. Certified Nurse Midwives (CNMs), Certified Professional Midwives (CPMs), and Certified Midwives (CMs) have different state recognition. Doulas aren’t licensed in any state but still face FTC rules on marketing claims. Birth center operations add facility-level considerations. This post covers the compliance framework.

Licensure variation

  • CNMs. Certified Nurse Midwives hold RN plus midwifery certification; licensed or recognized in all 50 states, with scope varying.
  • CPMs. Certified Professional Midwives are licensed in some states, not recognized in others, and illegal to practice as in a few.
  • CMs. Certified Midwives hold midwifery certification without RN; recognized in limited states.
  • Doulas. Not licensed; certification through various organizations (DONA, CAPPA, others) is credentialing but not state licensing.

Marketing should accurately reflect licensing status in your state. Using midwifery credentials in states where they’re not recognized creates specific exposure.

Scope of practice

Midwifery scope varies significantly by state and credential:

  • Prescribing authority varies dramatically.
  • Hospital vs home birth settings affect scope.
  • Physician collaboration requirements vary.
  • Emergency-transfer protocols vary.

Marketing should accurately represent what services are provided under what authority.

Problem marketing patterns

Pattern 1: Birth outcome guarantees

“Guaranteed natural birth,” “guaranteed VBAC success.” Birth outcomes vary significantly by individual factors. Guarantee language creates substantial substantiation issues.

Pattern 2: Hospital-birth disparagement

Marketing that disparages hospital birth or cesarean delivery creates professional-conduct issues and FTC comparative-claim concerns.

Pattern 3: Physician-equivalence implications

Marketing that implies midwives provide obstetric care equivalent to physicians. Scope varies; marketing should reflect actual scope rather than implying broader equivalence.

Pattern 4: Safety-absolute claims

“Safer than hospital birth” comparative claims need head-to-head substantiation reflecting population differences. Research on home vs hospital birth shows varying outcomes depending on how studies are structured; marketing claims need to reflect this nuance.

Pattern 5: Doula scope overreach

Doulas providing clinical services (vaginal exams, fetal heart monitoring) exceed typical doula scope. Marketing clinical-level services as doula services creates scope-of- practice and liability issues.

Birth center considerations

Licensed birth centers face additional layers:

  • State licensing for the facility.
  • AABC (Commission for the Accreditation of Birth Centers) accreditation if pursued.
  • Insurance billing and marketing considerations.
  • Transfer agreements with hospitals.

Compliant midwifery/doula marketing framework

  • Accurate licensure and credential representation.State-specific.
  • Conservative outcome framing. Birth outcomes vary; individual factors matter; informed consent is essential.
  • Collaborative framing. Working alongside obstetric care rather than against it.
  • Scope-appropriate service description.What midwives and doulas specifically provide.
  • Honest safety framing. Research-based rather than advocacy-based claims about safety comparisons.

Frequently asked questions

Can I practice as a CPM in states that don’t license them?

This is a legal question with state-specific answers. Marketing practice in states that don’t recognize the credential creates specific exposure separate from practice legality.

How should doulas represent their role?

Accurately - doulas provide emotional, informational, and physical support during pregnancy, birth, and postpartum. Marketing should accurately represent the non-clinical nature of doula support.

What about VBAC marketing?

VBAC (vaginal birth after cesarean) marketing needs to reflect the nuanced clinical reality - VBAC is appropriate for some patients with specific histories, not universal. Marketing as appropriate-for-all creates exposure.

Can I market home birth safety?

Evidence-matched framing. Research on home birth safety shows outcomes depend substantially on patient selection, provider credentials, and transfer arrangements. Blanket safety claims don’t reflect this nuance.

What about postpartum support services marketing?

Postpartum doula and postpartum midwifery services follow the same general framework. Specific claims about lactation, maternal mental health, or newborn outcomes need substantiation.

How do I handle insurance coverage marketing?

Insurance coverage for midwifery and doula services varies. Marketing coverage should reflect actual coverage patterns.

Built for this exact problem

Scan your clinic's content before regulators do.

RegenCompliance checks every word of your marketing against live FDA and FTC enforcement data - and rewrites violations automatically. A 30-second scan can save a $50,000–$5M regulatory response.

Apply for betaTry the free demo

Related in the platform

hub

All specialty playbooks

Weekly compliance brief

One email a week. New enforcement actions, rule changes, and tactical fixes. No spam, unsubscribe anytime.

We only send one email per week. No marketing blasts.

Keep reading

FDA Warning Letters at a 25-Year High: What Every Healthcare Practice Needs to Know in 2026

More than 200 FDA warning letters hit healthcare practices in 2024 - the highest volume in a quarter century. Here is what is being flagged, why regenerative medicine and med spas are on the front line, and what a defensible marketing program looks like now.

Read article

How a Single Social Media Post Can Become a Multi-Million-Dollar FTC Settlement

Multi-million-dollar FTC settlements against stem cell and regenerative medicine clinics now routinely start with a single Instagram caption or Facebook testimonial. Here is how that chain actually works - and the four places clinics lose control of it.

Read article

Structure/Function Claims vs. Disease Claims: The One FDA Distinction That Determines Whether Your Marketing Is Legal

One line separates legal marketing from a warning letter: the difference between a structure/function claim and a disease claim. Most practice owners think they know where the line is. They are usually wrong by one or two key phrases.

Read article